Por Renan Filho · 2026-11-05
**Lead**
A combination of political hesitation, budget pressures and inadequate containment measures in the United States has raised the spectre of a new influenza pandemic, according to health experts and international observers. While the immediate threat remains centred on the H5N1 avian flu virus circulating among American dairy cattle and poultry, the risk of a human-adapted strain emerging has intensified, prompting the United Kingdom to review its own preparedness strategies. The question is no longer whether another pandemic will strike, but whether the US political system is capable of mounting an effective response before it is too late.
**Context**
The H5N1 bird flu virus has been present in wild birds for decades, but its spread to mammals, including cattle, marks a worrying evolutionary step. Since early 2024, the US Department of Agriculture has confirmed outbreaks in dozens of dairy herds across multiple states, and the Centres for Disease Control and Prevention (CDC) has reported a small number of human cases, mostly among farm workers with direct exposure to infected animals. Although the virus does not yet transmit easily between people, each new human infection gives it another opportunity to acquire the mutations needed for sustained human-to-human spread.
Public health agencies in the US have been monitoring the situation, but their efforts have been hampered by political divisions and funding uncertainties. In recent months, Congress has debated cuts to the CDC’s influenza preparedness budget, while state-level responses have varied widely. Some states have imposed strict quarantine and testing regimes, while others have limited data sharing with federal authorities. This fragmented approach has frustrated international partners, who rely on timely and transparent information to assess the global risk.
The UK Health Security Agency (UKHSA) has been tracking the US outbreaks closely. British virologists and epidemiologists have repeatedly stressed that a pandemic originating in North America could reach UK shores within days, given the volume of transatlantic air travel. The UK has stockpiled antivirals and vaccines, but these are targeted at existing seasonal flu strains, not a novel avian-derived virus. Developing a new vaccine would take months, even under emergency procedures.
**Analise**
The political dimension cannot be overstated. The US is currently experiencing a period of intense polarisation over public health measures, a legacy of the COVID-19 pandemic. Vaccine mandates, mask requirements and even basic disease surveillance have become partisan issues. This environment makes it difficult for federal health officials to implement the kind of aggressive containment strategy that might prevent a wider outbreak. Farm owners and workers are often reluctant to cooperate with health authorities for fear of economic penalties or unwanted publicity. Without robust data collection and testing, the true extent of H5N1 circulation among humans remains unknown.
For the UK, the stakes are high. British public health experts have warned that the window for preventing a pandemic may be narrowing. The United Kingdom has its own poultry industry and wild bird populations that could serve as a reservoir for the virus if it arrives. Moreover, a pandemic that begins in the United States would likely strain international supply chains for vaccines and antiviral drugs, leaving countries with less purchasing power at the back of the queue. The UK, while relatively wealthy, is not immune to such dynamics, as the COVID-19 experience showed.
**Fontes**
This article draws on publicly available information from the World Health Organisation (WHO), the US Centres for Disease Control and Prevention (CDC), the UK Health Security Agency (UKHSA), and reports from the Reuters news agency and the BBC. Expert commentary referenced is based on statements issued by academic institutions and professional bodies, including the Royal Society and the American Society for Microbiology.